APA (7th ed.) Citation

Z, L., L, L., X, Y., Z, F., Y, X., K, L., . . . N, D. (2026). ITK-targeted immune remodeling enhanced the efficacy of anti-CD19 CAR-T cell therapy. Cell death discovery, 12(1), . https://doi.org/10.1038/s41420-026-03004-2

Chicago Style (17th ed.) Citation

Z, Li, et al. "ITK-targeted Immune Remodeling Enhanced the Efficacy of Anti-CD19 CAR-T Cell Therapy." Cell Death Discovery 12, no. 1 (2026). https://doi.org/10.1038/s41420-026-03004-2.

MLA (9th ed.) Citation

Z, Li, et al. "ITK-targeted Immune Remodeling Enhanced the Efficacy of Anti-CD19 CAR-T Cell Therapy." Cell Death Discovery, vol. 12, no. 1, 2026, https://doi.org/10.1038/s41420-026-03004-2.